There is a close relationship between the human gut microbiota and human health.
Yet, we still understand very little about the ecosystem inside our gut.
At MedBiome, we believe that studying the human gut microbiome and its impacts on human health will transform how we conduct drug development, and eventually lead to innovative ways of treating diseases.
MedBiome has developed a series of unique core technologies related to compound screening against individual microbiomes that it can deploy for a number of applications relevant to drug discovery and development.
Accelerated drug discovery
Lead candidate identification & validation
Patient profiling & stratification
MedBiome focuses on the development of drugs that target the human microbiome. Our mission is to identify drugs that target the microbiome to improve human health.
MedBiome was launched in 2018 as the result of technologies developed at the University of Ottawa.
MedBiome is located in Ottawa, ON, Canada.
© 2019. MedBiome, Inc. All Rights Reserved.